APA-referens

Ueda, Y., Enokida, T., Okano, S., Fujisawa, T., Ito, K., & Tahara, M. (2020). Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. Front Oncol.

Chicago-stil citat

Ueda, Yuri, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Kazue Ito, och Makoto Tahara. "Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) As First-Line Treatment in Patients With Recurrent And/or Metastatic Nasopharyngeal Carcinoma." Front Oncol 2020.

MLA-referens

Ueda, Yuri, et al. "Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) As First-Line Treatment in Patients With Recurrent And/or Metastatic Nasopharyngeal Carcinoma." Front Oncol 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.